AbbVie
ABBV
#38
Rank
$235.18 B
Marketcap
$133.03
Share price
-1.61%
Change (1 day)
18.12%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Revenue for AbbVie (ABBV)

Revenue in 2021 (TTM): $55.16 B

According to AbbVie's latest financial reports the company's current revenue (TTM) is $55.16 B. In 2020 the company made a revenue of $45.80 B an increase over the years 2019 revenue that were of $33.26 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AbbVie from 2011 to 2021

Year Revenue Change
2021 (TTM)$55.16 B20.45%
2020$45.80 B37.69%
2019$33.26 B1.57%
2018$32.75 B16.08%
2017$28.21 B10.06%
2016$25.63 B12.16%
2015$22.85 B14.52%
2014$19.96 B6.23%
2013$18.79 B2.23%
2012$18.37 B5.36%
2011$17.44 B